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.2012.02.Abstract Background: Functional Endoscopic sinus surgery (FESS) is a delicate and time con-
suming procedure; it is performed routinely under general anesthesia. Hypotensive techniques
should be employed for best visualization of operative ﬁeld. Gabapentin is a structural analog of
gamma amino butyric acid. The aim of this study was to determine the analgesic efﬁcacy of gaba-
pentin and its role in deliberate hypotension during and after FESS.
Methods: Eighty patients ASA physical status I–II patients were scheduled to undergo elective
FESS under general anesthesia. Patients were randomly assigned to one of two groups using a com-
puter-generated table. Patients in the control group (40 patients) received oral placebo capsules and
the study group (40 patients) patients received oral gabapentin (Conventin 400 mg; Evapharma
Egypt) 1.2 g 1 h before surgery. Intraoperative, mean arterial blood pressure, infusion rates of
the hypotensive agent (sodium nitroprusside) were recorded at 15 min interval. Assessments of pain,
opioid usage, and side effects were performed at 1 h interval after arrival in the PACU.
Results: Gabapentin group patients required signiﬁcantly lower (p value <0.05) infusion rates and
total doses of hypotensive agent (sodium nitroprusside) than the placebo group patients at all
measured intervals. Postoperative assessment of pain scores revealed that gabapentin group
recorded signiﬁcantly lower mean values of VAS than the control group (p value <0.05).02 24145837, mobile: +20
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190 M.H. Mohammed et al.Conclusion: Oral gabapentin, 1200 mg decreased dose requirements of intraoperative hypotensive
agent (sodium nitroprusside) and postoperative morphine. In addition, patients receiving gabapen-
tin had suffered less from opioid side effects (nausea, vomiting and urinary retention) than those
receiving placebo.
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Open access under CC BY-NC-ND license.1. Introduction
The multiplicity of mechanisms involved in pain requires a
multimodal analgesia regimen, suggesting that a combination
of opioid and non-opioid analgesic drugs may improve analge-
sic efﬁcacy and reduce opioid requirements and side effects
after surgery. A number of analgesic regimens can be used
for pain relief in day-case surgery patients. These regimens in-
clude the use of opioids, local anesthetics, nonsteroidal antiin-
ﬂammatory drugs (NSAIDs), and cyclooxygenase-2 inhibitors
[1].
Gabapentin, a structural analog of gamma amino butyric
acid, which was ﬁrst developed as an antiepileptic drug. It
was ﬁrst reported to be effective for treatment of neuropathic
pain [2] and diabetic neuropathy [3]. It has also been shown to
reduce postoperative pain and opioid analgesic requirements
in a variety of acute postoperative pain models [4–8].
As Functional Endoscopic sinus surgery (FESS) is a deli-
cate and time consuming procedure, it is performed routinely
under general anesthesia, so anesthesiologists have to plan
the technique in such a way that will facilitate the operating
team for achieving a bloodless ﬁeld for better visualization
of the intranasal structures and minimize intraoperative bleed-
ing. Because very little bleeding can obstruct the view of the
operating endoscope, hypotensive anesthesia should be em-
ployed [9].
Although postoperative pain is typically regarded as a type
of nociceptive pain involving peripheral mechanoreceptor
stimulation, it is clear that inﬂammatory, neurogenic, and vis-
ceral mechanisms also contribute to acute pain symptoms. It
has been suggested that postoperative pain can be associated
with a transient, reversible type of neuropathic pain [10]. An
animal study demonstrated that gabapentin could reduce vis-
ceral nociception [11,15].
Early clinical studies of surgical patients suggested that pre-
operative administration of gabapentin decreased postopera-
tive pain scores and opioid analgesic requirements after
mastectomy [12,13], spinal surgery [7], and otolaryngologic
surgery [6].
These results should be validated and other surgical pain
models used before a reliable conclusion can be reached. The
aim of this study was to determine the analgesic efﬁcacy of
gabapentin and its role in deliberate hypotension during and
after FESS.2. Methods
The study was conducted in Ain Shams University hospitals at
the ENT surgical department. After approval of the institu-
tional ethics committee and written informed consent; 80
patients ASA physical status I–II patients were studied. All
were scheduled to undergo elective functional endoscopic sinussurgery under general anesthesia. Patients were chosen to par-
ticipate in the study if they were at least 18 years old, willing to
comply with the postoperative follow-up evaluations, within
50% of ideal body weight, had no clinically signiﬁcant cardio-
vascular or central nervous system disease, and could operate a
patient-controlled analgesia (PCA) device.
Exclusion criteria were age younger than 18 years or older
than 50 years, history of chronic pain, regular medications
with analgesics, analgesic use within 24 h of surgery, drug or
alcohol abuse, psychiatric disorders, known allergy or contra-
indications to anesthetics or any drug used, asthma, renal
insufﬁciency, hepatic disorder, history of a peptic ulcer or
bleeding diathesis and pregnancy. The patients were randomly
assigned to one of two groups using a computer-generated ta-
ble. Patients in the control group (40 patients) received oral
placebo capsules and the study group (40 patients) patients re-
ceived oral gabapentin (Conventin 400 mg; Evapharma Egypt)
1.2 g 1 h before scheduled time for surgery. All given capsules
were prepared by the pharmacy in order to maintain double-
blind conditions, and an appropriate code number was as-
signed to each patient. Baseline mean arterial blood pressure,
heart rate, and peripheral oxygen saturation values were ob-
tained using standard monitors. After giving the oral medica-
tion 22 gauge intravenous line was inserted and 500 ml lactated
Ringer’s solution i.v. infusion was started in all patients, then
midazolam, 0.05 mg/kg intravenously 45 min were given be-
fore surgery. An intra-arterial catheter was inserted under local
anesthesia in the radial artery for direct measurement of arte-
rial blood pressure. After 1 h of oral medication, anesthesia
was induced with propofol (2 mg/kg) and atracurium
(0.5 mg/kg) and fentanyl 2 lg/kg intravenously. Endotracheal
intubation was done followed by mechanical ventilation in or-
der to maintain the end expiratory CO2 values between 34–
36 mm Hg. Anesthesia was maintained with isoﬂurane 1.5%
at a fresh gas ﬂow rate of 2 l/min. Intraoperative mean arterial
blood pressure was recorded at 5 min interval. After successful
induction, sodium nitroprusside infusion started at a rate of
0.5 lg/kg/min, this rate was subjected to change (increased
or decreased) in order to maintain a mean arterial blood pres-
sure (45–50 mm Hg). Rate of infusion of sodium nitroprusside
were recorded every 5 min, then at the end of the procedure.
Morphine 2 mg IV was administered immediately before dis-
continuing isoﬂurane. At the end of surgery, residual neuro-
muscular blockade was antagonized with neostigmine 50 lg/
kg and atropine 0.01 mg/kg IV.
After arrival in the post anesthesia care unit (PACU), pa-
tients were connected to a PCA device and postoperative anal-
gesia was provided using 2 mg IV bolus injections of morphine
at a lockout interval of 10 min and with a maximum 4 h limit
of 40 mg. The incremental bolus dose of morphine was in-
creased to 3 mg if analgesia was inadequate (pain score by
visual analogue scale (VAS) was more than 4 cm after the ﬁrst
hour of PCA use.
Table 2 Cumulative morphine consumption at 8 h, and time
to ﬁrst morphine request in the post anesthesia care unit.
Control
(Mean± SD)
Gabapentin
(Mean± SD)
First morphine request (min) 20±8 40±5
Morphine consumption (mg) 14±2 8±1
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Figure 2 Postoperative morphine consumption.
Preoperative gabapentin augments intraoperative hypotension 191Assessments of pain, opioid usage, and side effects were
performed at 1 h interval after arrival in the PACU by a re-
search assistant blinded to the group allocation till end of
PCA usage. The PCA device was discontinued when the pa-
tient made no demands for the opioid analgesic in the preced-
ing 8 h interval. If the patient experienced sustained nausea or
vomiting lasting longer than 5 min, ondansetron (4 mg IV) was
administered.
Data analysis was made by using SPSS 14.0 for Windows.
Comparison between the two groups as regards numerical
variables was made by using Student-t-test for comparing
means and standard deviation. Signiﬁcant results were deﬁned
when the p value was less than 0.05.
3. Results
There were no signiﬁcant differences between groups with re-
spect to ASA classiﬁcation, age, weight, duration of surgery,
preoperative mean blood pressure or duration of anesthesia
(Table 1). No patient was excluded after inclusion to study.
All patients were able to complete the entire study and their
data were included in the ﬁnal analysis.
Gabapentin group patients had signiﬁcantly lower (p value
<0.05) infusion rates of sodium nitroprusside than the pla-
cebo group patients at all measured intervals (Fig. 1).0
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Figure 1 Intraoperative infusion rates of sodium nitroprusside in
the two study groups.
Table 1 Patient’s characteristics and operative data
Variable Gabapentin
(n= 40)
Placebo (n= 40)
ASA classiﬁcation (I/II) 35/5 36/4
Age (yr) 30.6 ± 6.1 33.7 ± 4.2
Weight (kg) 71.6 ± 5.3 69.1 ± 5.9
Duration of anesthesia (min) 82.7 ± 11.5 79.9 ± 9.5
Duration of surgery (min) 70.9 ± 10.2 68.3 ± 11.4
Preoperative mean
blood pressure (mm Hg)
70.5 ± 11.1 71.2 ± 10.8
Average intraoperative
blood loss (ml)
200.1 ± 40.3 250.6 ± 30.9
Table 3 Incidence of nausea and vomiting in the two study
groups.
Control (n= 40) Gabapentin (n= 40)
Nausea 10 (25%) 3 (7.5%)
Vomiting 5 (12.5%) 1 (2.5%)
Use of antiemetic drugs 10 (25%) 2 (5%)
Urinary retention 1 0The time until the ﬁrst request for analgesia (morphine) in
the PACU was longer in the gabapentin than in the control
group (40 ± 5 min) compared to the placebo group
(20± 8 min) (Table 2). Compared with the control group,
PCA morphine requirement was signiﬁcantly lower in the
gabapentin group at 1, 2, 3, 4, 5 and 6 h after surgery
(Fig. 2). Postoperative assessment of morphine usage revealed
that gabapentin group recorded a signiﬁcantly lower values of
morphine consumption than the control group (p value <0.05)
(Table 2).
The most common side effects during the postoperative per-
iod were nausea and vomiting. The incidence of nausea was
signiﬁcantly less frequent in the gabapentin group compared
with the placebo group (10) compared to the placebo group
(3). Not surprisingly, antiemetic usage was also signiﬁcantly
reduced in the gabapentin (versus placebo) group. One patient
of the placebo group suffered from urinary retention for 8 h
postoperatively, not surprisingly, this patient received the
highest amount of morphine of the whole study patients
(Table 3).
4. Discussion
Perioperative administration of gabapentin, as part of a multi-
modal analgesic regimen with PCA morphine, led to improved
192 M.H. Mohammed et al.pain control and reduced opioid-related side effects by reduc-
ing the doses of opioids required. Moreover, intraoperative
usage of intravenous hypotensive agent was signiﬁcantly
reduced.
In animal models of nociception, gabapentin reduced
mechanical or thermal hyperalgesia [16] and incisional injury
[11]. Pretreatment with gabapentin also blocked the develop-
ment of hyperalgesia, suggesting a preventive effect of gaba-
pentin, and had a selective effect on the nociceptive process
involving central sensitization [14]. Studies have demonstrated
that mechanical hyperalgesia surrounding the wound in post-
operative patients and experimentally heat induced secondary
hyperalgesia share a common mechanism and that central neu-
ronal sensitization contributes to postoperative pain [10].
Thus, drugs such as gabapentin, which have been effective
in reducing hyperalgesia in different models of pain, may play
an important role in acute postoperative pain in humans [17].
Studies suggest that gabapentin may be useful in the periop-
erative setting, as an adjuvant to parenteral opioid analgesics
in the postoperative period [4–8].
Our study shows a different usage through improving intra-
operative hypotension required for sinus surgery.
In summary, oral gabapentin 1200 mg decreased the dose
requirement of morphine and postoperative pain and improves
intraoperative hypotension required for sinus surgery.
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